Title: Harnessing plant-derived bioactive compounds and microbial biotechnology to combat antimicrobial resistance
Abstract:
Antimicrobial resistance (AMR) has evolved as major public health challenges worldwide. Disease causing microorganism become resistant day by day due to various factors. The speedy evolution of multidrug-resistant disease causing microorganisms necessitates the development of innovative, sustainable, and biologically relevant therapeutic strategies. Biotechnology offers a promising platform for discovering novel antimicrobial agents by integrating the therapeutic potential of medicinal plants with advances in microbial biotechnology. This findings explores the role of plant-derived bioactive compounds and beneficial microorganisms in addressing antimicrobial resistance through multidisciplinary biotechnological approaches.
The antimicrobial potential of selected medicinal plant extracts and their synergistic interactions with conventional antibiotics against clinically important bacterial pathogens. Emphasis will be placed on the diverse phytochemicals, including phenolics, flavonoids, alkaloids, terpenoids, and essential oils, which exhibit broad-spectrum antimicrobial properties through multiple mechanisms of action. Their ability to enhance antibiotic efficacy, inhibit biofilm formation, disrupt bacterial quorum sensing, and reduce the emergence of resistant strains will be discussed. Furthermore, microbial biotechnology approaches, including the screening of beneficial microorganisms for antimicrobial metabolite production, enzyme-mediated biotransformation, and eco-friendly & sustainable bioprocesses, will be presented as sustainable alternatives for developing next-generation antimicrobial therapeutics.
The presentation also focuses the importance of integrating phytochemical research biotechnology, microbiology, molecular biology, and bioengineering to accelerate the discovery and validation of novel antimicrobial agents. Recent advances in plant tissue culture, metabolomics, microbial fermentation, and nanobiotechnology have significantly expanded the scope of producing standardized bioactive compounds with improved quality, stability, bioavailability, sustainability and therapeutic efficacy. Such interdisciplinary approaches contribute to reducing dependence on synthetic antibiotics while promoting environmentally sustainable healthcare solutions.
By bridging natural bioactive product research with microbial biotechnology, this work demonstrates how biotechnology can contribute to combating antimicrobial resistance and improving global health populations. The presentation aligns with current international efforts to develop innovative antimicrobial strategies and supports the conference theme, "Advancing Biotechnology & Bioengineering: From Concepts to Impact," by emphasizing translational research that transforms scientific discoveries into practical healthcare applications. This integrated approach has the potential to inspire future collaborative research and accelerate the development of safe, effective, and sustainable antimicrobial interventions.
